Tokyo Tape
Sign in
← SymBio Pharmaceuticals

Annual report

4582.TEDINET S100VGDJ
Period2024-01-01 → 2024-12-31
Filed2025-03-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 121
MetricValuePeriodScopeSource row
Revenue¥2.5bn2024-01-01 → 2024-12-31Cons.Net sales
Revenue¥5.6bn2023-01-01 → 2023-12-31Cons.Net sales
Revenue¥10.0bn2022-01-01 → 2022-12-31dCons.Net sales (5-year summary)
Operating income−¥3.9bn2024-01-01 → 2024-12-31Cons.Operating income
Operating income−¥812m2023-01-01 → 2023-12-31Cons.Operating income
Ordinary income−¥3.7bn2024-01-01 → 2024-12-31Cons.Ordinary income
Ordinary income−¥736m2023-01-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥2.0bn2022-01-01 → 2022-12-31dCons.Ordinary income loss (5-year summary)
Profit before tax−¥3.8bn2024-01-01 → 2024-12-31Cons.Income before income taxes
Profit before tax−¥1.2bn2023-01-01 → 2023-12-31Cons.Income before income taxes
Net income (owners)−¥3.8bn2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥2.0bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.2bn2022-01-01 → 2022-12-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income−¥3.8bn2024-01-01 → 2024-12-31Cons.Profit loss
Net income−¥2.0bn2023-01-01 → 2023-12-31Cons.Profit loss
Total assets¥5.0bnat 2024-12-31Cons.Assets
Total assets¥8.2bnat 2023-12-31Cons.Assets
Total assets¥10.4bnat 2022-12-31dCons.Total assets (5-year summary)
Total liabilities¥771mat 2024-12-31Cons.Liabilities
Total liabilities¥960mat 2023-12-31Cons.Liabilities
Net assets / equity¥4.2bnat 2024-12-31Cons.Net assets
Net assets / equity¥7.2bnat 2023-12-31Cons.Net assets
Net assets / equity¥8.5bnat 2022-12-31dCons.Net assets
Cash and deposits¥4.0bnat 2024-12-31Cons.Cash and deposits
Cash and deposits¥6.5bnat 2023-12-31Cons.Cash and deposits
Cash & equivalents¥4.0bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥6.5bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥6.3bnat 2022-12-31dCons.Cash and cash equivalents
Operating cash flow−¥3.4bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥195m2023-01-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.6bn2022-01-01 → 2022-12-31dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥4m2024-01-01 → 2024-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥377m2023-01-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥47m2022-01-01 → 2022-12-31dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow¥708m2024-01-01 → 2024-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥680m2023-01-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥628m2022-01-01 → 2022-12-31dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥-852024-01-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-49.192023-01-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.22022-01-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥29.772022-01-01 → 2022-12-31dCons.Diluted earnings per share (5-year summary)
Net assets per share¥84.66at 2024-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥164.32at 2023-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥204.83at 2022-12-31dCons.Net assets per share (5-year summary)
Equity ratio78.1%at 2024-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio84.9%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio77.6%at 2022-12-31dCons.Equity to asset ratio (5-year summary)
ROE14.6%2022-01-01 → 2022-12-31dCons.Rate of return on equity (5-year summary)
Employees108at 2024-12-31Cons.Number of employees
Employees109at 2023-12-31Cons.Number of employees
Employees122at 2022-12-31dCons.Number of employees
Revenue¥2.5bn2024-01-01 → 2024-12-31StandaloneNet sales
Revenue¥5.6bn2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥10.0bn2022-01-01 → 2022-12-31dStandaloneNet sales (5-year summary)
Revenue¥8.3bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥3.0bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Operating income−¥4.0bn2024-01-01 → 2024-12-31StandaloneOperating income
Operating income−¥852m2023-01-01 → 2023-12-31StandaloneOperating income
Ordinary income−¥3.8bn2024-01-01 → 2024-12-31StandaloneOrdinary income
Ordinary income−¥774m2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income¥2.0bn2022-01-01 → 2022-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥1.0bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥4.6bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥3.9bn2024-01-01 → 2024-12-31StandaloneIncome before income taxes
Profit before tax−¥1.2bn2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Net income−¥3.9bn2024-01-01 → 2024-12-31StandaloneProfit loss
Net income−¥2.0bn2023-01-01 → 2023-12-31StandaloneProfit loss
Net income¥1.2bn2022-01-01 → 2022-12-31dStandaloneNet income loss (5-year summary)
Net income¥2.0bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income−¥4.1bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Total assets¥4.7bnat 2024-12-31StandaloneAssets
Total assets¥8.2bnat 2023-12-31StandaloneAssets
Total assets¥10.4bnat 2022-12-31dStandaloneTotal assets (5-year summary)
Total assets¥8.5bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥6.3bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥639mat 2024-12-31StandaloneLiabilities
Total liabilities¥980mat 2023-12-31StandaloneLiabilities
Net assets / equity¥4.1bnat 2024-12-31StandaloneNet assets
Net assets / equity¥7.2bnat 2023-12-31StandaloneNet assets
Net assets / equity¥8.5bnat 2022-12-31dStandaloneNet assets
Net assets / equity¥6.7bnat 2021-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥4.7bnat 2020-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥3.7bnat 2024-12-31StandaloneCash and deposits
Cash and deposits¥6.3bnat 2023-12-31StandaloneCash and deposits
Cash & equivalents¥3.9bnat 2021-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.8bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥140m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥4.1bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥71m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥160m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥72m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.2bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-872024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-49.792023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥30.372022-01-01 → 2022-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥53.042021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-124.132020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥29.952022-01-01 → 2022-12-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥52.322021-01-01 → 2021-12-31dStandaloneDiluted earnings per share (5-year summary)
Net assets per share¥82.12at 2024-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥164.02at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥204.95at 2022-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥162.26at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥105.76at 2020-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio79.7%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio84.6%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio77.8%at 2022-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio73.7%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio64.3%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE16.6%2022-01-01 → 2022-12-31dStandaloneRate of return on equity (5-year summary)
ROE39.6%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued45,928,856at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued42,278,081at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued39,603,606at 2022-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued38,457,206at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued38,202,956at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees101at 2024-12-31StandaloneNumber of employees
Employees103at 2023-12-31StandaloneNumber of employees
Employees118at 2022-12-31dStandaloneNumber of employees
Employees141at 2021-12-31dStandaloneNumber of employees
Employees127at 2020-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 1
SegmentItemPeriodValue
Research And Development Manufacturing And Sales Of Pharmaceuticals Etc And Related Businessreportable segmentemployeesat 2024-12-31108 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,250
ItemContextValueUnit
Name of shareholder treasury shares etcCurrentYearInstant_Row1Member
Original text (Japanese) シンバイオ製薬株式会社
Address of shareholder treasury shares etcCurrentYearInstant_Row1Member
Original text (Japanese)東京都港区虎ノ門四丁目１番２８号
Classes of shares etc (text)FilingDateInstantText · Plus
Acquisitions by resolution of shareholders meeting (text)FilingDateInstantText · Plus
Acquisitions by resolution of board of directors meeting (text)FilingDateInstantText · Plus
Acquisitions not based on resolution of shareholders meeting or board of directors meeting (text)FilingDateInstantText · Plus
Disposals or holding of acquired treasury shares (text)FilingDateInstantText · Plus
Dividend policy (text)FilingDateInstantText · Plus
Overview of corporate governance (text)FilingDateInstantText · Plus
Corporate governance company with audit and supervisory committee (text)FilingDateInstantText · Plus
Information about officers (text)FilingDateInstantText · Plus
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000YoshidaFuminoriMember
Original text (Japanese)代表取締役社長執行役員(CEO)
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000YoshidaFuminoriMember
Original text (Japanese)吉 田 文 紀
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000YoshidaFuminoriMember1949-01-19
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E24682-000YoshidaFuminoriMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000YoshidaFuminoriMember
Original text (Japanese)(注)１
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000MatsumotoShigetoshiMember
Original text (Japanese)取締役
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000MatsumotoShigetoshiMember
Original text (Japanese)松本 茂外志
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000MatsumotoShigetoshiMember1949-08-12
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E24682-000MatsumotoShigetoshiMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000MatsumotoShigetoshiMember
Original text (Japanese)(注)１
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000BruceDavidChesonMember
Original text (Japanese)取締役
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000BruceDavidChesonMember
Original text (Japanese)ブルース・デビッド・ チェソン
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000BruceDavidChesonMember1946-04-06
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E24682-000BruceDavidChesonMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000BruceDavidChesonMember
Original text (Japanese)(注)１
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000EbinumaEijiMember
Original text (Japanese)取締役
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000EbinumaEijiMember
Original text (Japanese)海老沼 英次
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000EbinumaEijiMember1957-07-03
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E24682-000EbinumaEijiMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000EbinumaEijiMember
Original text (Japanese)(注)１
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000ImabeppuToshioMember
Original text (Japanese)取締役
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000ImabeppuToshioMember
Original text (Japanese)今別府　敏雄
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000ImabeppuToshioMember1956-07-13
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E24682-000ImabeppuToshioMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000ImabeppuToshioMember
Original text (Japanese)(注)１
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000MostynGeorgeMember
Original text (Japanese)取締役
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000MostynGeorgeMember
Original text (Japanese)ジョージ・モースティン
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000MostynGeorgeMember1950-12-28
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E24682-000MostynGeorgeMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000MostynGeorgeMember
Original text (Japanese)(注)１
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000LalphSmallingMember
Original text (Japanese)取締役
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000LalphSmallingMember
Original text (Japanese)ラルフ・スモーリング
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000LalphSmallingMember1955-09-15
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E24682-000LalphSmallingMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000LalphSmallingMember
Original text (Japanese)(注)１
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000WatanabeKiyoshiMember
Original text (Japanese)取締役 (常勤監査等委員)
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000WatanabeKiyoshiMember
Original text (Japanese)渡 部　潔
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24682-000WatanabeKiyoshiMember1951-05-16
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E24682-000WatanabeKiyoshiMemberText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2023-12-31pass
balance sheet identityconsolidated 2024-12-31pass rounding
balance sheet identitynon_consolidated 2023-12-31pass
balance sheet identitynon_consolidated 2024-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsconsolidated 2024-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-12-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass